Hahn Mark W's Form 4 filing
Verona Pharma plc (VRNA) · filed Dec 2, 2024
- Accession no.
- 0001104659-24-124757
- Filed
- Dec 2, 2024
- Trade date
- Nov 27-Dec 2, 2024
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $567.2K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hahn Mark WCIK 0001408502 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 27, 2024 | Ordinary Shares | SSaleDisposed | −12,936 | $5.00 | −$64,680 | 14,276,000 | Direct | |
| Nov 29, 2024 | Ordinary Shares | SSaleDisposed | −98,704 | $5.01 | −$494,507.04 | 14,177,296 | Direct | |
| Dec 2, 2024 | Ordinary Shares | SSaleDisposed | −1,600 | $5.00 | −$8,000 | 14,175,696 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.